{"id":73238,"date":"2026-10-19T08:38:18","date_gmt":"2026-10-19T12:38:18","guid":{"rendered":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/market-movers-microsoft-shifts-ai-strategy-merck-kgaa-inks-1-3b-biotech-deal-and-intel-gains-analyst-favor\/73238\/"},"modified":"2026-10-19T08:38:18","modified_gmt":"2026-10-19T12:38:18","slug":"market-movers-microsoft-shifts-ai-strategy-merck-kgaa-inks-1-3b-biotech-deal-and-intel-gains-analyst-favor","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/market-movers-microsoft-shifts-ai-strategy-merck-kgaa-inks-1-3b-biotech-deal-and-intel-gains-analyst-favor\/73238\/","title":{"rendered":"Market Movers: Microsoft Shifts AI Strategy, Merck KGaA Inks $1.3B Biotech Deal, and Intel Gains Analyst Favor"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>Merck KGaA (<a href=\"\/stock\/MKGAY\">MKGAY<\/a>)<\/strong> to acquire <strong>Silence Therapeutics (<a href=\"\/stock\/SLN\">SLN<\/a>)<\/strong> for <strong>$20.00 per ADS<\/strong> in an all-cash deal valued at approximately <strong>$1.3 billion<\/strong>, representing a <strong>130% premium<\/strong> to its last closing price.<\/li>\n<li><strong><a href=\"https:\/\/stockmarketwatch.com\/stock\/MSFT\" data-internallinksmanager029f6b8e52c=\"18\" title=\"Stock: MSFT\">Microsoft<\/a> (<a href=\"\/stock\/MSFT\">MSFT<\/a>)<\/strong> has withdrawn from a major UK AI data center project with <strong>Nscale<\/strong> due to power grid delays, though it maintains its broader partnership with the <a href=\"https:\/\/stockmarketwatch.com\/stock\/NVDA\" data-internallinksmanager029f6b8e52c=\"15\" title=\"stock: NVDA\">Nvidia<\/a>-backed startup.<\/li>\n<li><strong>Intel (<a href=\"\/stock\/INTC\">INTC<\/a>)<\/strong> shares rose <strong>4%<\/strong> in <a href=\"https:\/\/stockmarketwatch.com\/movers\/premarket\" data-internallinksmanager029f6b8e52c=\"7\" title=\"Premarket Movers\">pre-market trading<\/a> following a <strong>JPMorgan<\/strong> upgrade to <strong>Neutral<\/strong>, with analysts citing improved execution and rising demand for agentic AI workloads.<\/li>\n<li><strong>Canada\u2019s September CPI<\/strong> cooled more than expected to <strong>3.1% (YoY)<\/strong>, while core inflation measures remained steady, potentially influencing the Bank of Canada\u2019s upcoming rate decision.<\/li>\n<li><strong>Cleveland-Cliffs (<a href=\"\/stock\/CLF\">CLF<\/a>)<\/strong> shares surged <strong>12%<\/strong> after reporting a third-quarter profit beat and issuing a strong <strong>$715 million<\/strong> EBITDA outlook for the next quarter.<\/li>\n<\/ul>\n<h2>Corporate M&amp;A and Strategic Shifts<\/h2>\n<p><strong>Merck KGaA (<a href=\"\/stock\/MKGAY\">MKGAY<\/a>)<\/strong> announced a definitive agreement to acquire <strong>Silence Therapeutics (<a href=\"\/stock\/SLN\">SLN<\/a>)<\/strong> for <strong>$20 per ADS<\/strong> in cash. The deal, valued at <strong>$1.3 billion<\/strong>, aims to bolster Merck\u2019s rare disease pipeline with Silence\u2019s siRNA (short interfering RNA) technology. The offer represents a massive <strong>130% premium<\/strong> over the October 16 closing price, signaling intense competition for advanced genomic medicine assets.<\/p>\n<p><strong><a href=\"https:\/\/stockmarketwatch.com\/stock\/MSFT\" data-internallinksmanager029f6b8e52c=\"18\" title=\"Stock: MSFT\">Microsoft<\/a> (<a href=\"\/stock\/MSFT\">MSFT<\/a>)<\/strong> has canceled its anchor tenancy at a planned <strong>Nscale<\/strong> data center in Loughton, UK. The decision follows reports that the site would not receive a sufficient power connection until after <strong>2030<\/strong>. Despite the exit from this specific site, <strong><a href=\"https:\/\/stockmarketwatch.com\/stock\/MSFT\" data-internallinksmanager029f6b8e52c=\"18\" title=\"Stock: MSFT\">Microsoft<\/a><\/strong> reaffirmed its commitment to the broader partnership with <strong>Nscale<\/strong>, which is currently preparing for a <strong>$35 billion<\/strong> New York IPO.<\/p>\n<h2>Semiconductor and Tech Momentum<\/h2>\n<p><strong>Intel (<a href=\"\/stock\/INTC\">INTC<\/a>)<\/strong> received a significant sentiment boost as <strong>JPMorgan<\/strong> upgraded the stock to <strong>Neutral<\/strong> from Underweight. Analyst Harlan Sur noted that improved operational execution under CEO Lip-Bu Tan and the growth of <em>CPU-intensive agentic AI<\/em> are driving positive earnings revisions. The firm highlighted that the recent <strong>36% pullback<\/strong> in Intel&#39;s share price has created a more balanced risk-reward profile for investors.<\/p>\n<p><strong>Skyworks Solutions (<a href=\"\/stock\/SWKS\">SWKS<\/a>)<\/strong> gained <strong>1.2%<\/strong> following positive mentions from activist investor <strong>Starboard Value<\/strong>. The firm believes <strong>Skyworks<\/strong> remains undervalued after its <strong>$22 billion<\/strong> acquisition of <strong>Qorvo<\/strong>. Starboard expects the merger to generate over <strong>$500 million<\/strong> in annual cost synergies and drive operating margins toward a <strong>30%-35%<\/strong> target within three years.<\/p>\n<h2>Industrial and Healthcare Developments<\/h2>\n<p><strong>Cleveland-Cliffs (<a href=\"\/stock\/CLF\">CLF<\/a>)<\/strong> reported third-quarter adjusted EPS of <strong>$0.28<\/strong>, beating the <strong>$0.22<\/strong> analyst consensus. The steelmaker&#39;s stock jumped <strong>12%<\/strong> as management projected a significant rise in fourth-quarter adjusted EBITDA to <strong>$715 million<\/strong>. The company&#39;s performance was bolstered by higher steel shipments totaling <strong>4.2 million net tons<\/strong> and improved average selling prices.<\/p>\n<p><strong>Johnson &amp; Johnson (<a href=\"\/stock\/JNJ\">JNJ<\/a>)<\/strong> released new Phase 3 data for <strong>TREMFYA (guselkumab)<\/strong>, showing it is the only IL-23 inhibitor to deliver durable fistula remission through <strong>48 weeks<\/strong> in Crohn\u2019s disease patients. The study showed remission rates increased to <strong>35%<\/strong> by week 48, reinforcing the drug&#39;s competitive position in the high-stakes immunology market.<\/p>\n<h2>Global Macro and Geopolitical Alerts<\/h2>\n<p><strong>Canada\u2019s inflation<\/strong> data for September showed a headline increase of <strong>3.1% (YoY)<\/strong>, slightly below the <strong>3.2%<\/strong> estimate. Monthly CPI rose just <strong>0.1%<\/strong>, indicating a continued cooling of price pressures. This data provides the <strong>Bank of Canada<\/strong> with more flexibility as it prepares for its October 28 interest rate announcement.<\/p>\n<p>In the Middle East, <strong>Saudi Civil Defense<\/strong> issued an emergency alert for the <strong>Najran<\/strong> region following a &quot;hostile projectile&quot; strike that injured six citizens. The escalating regional tensions have led several airlines, including <strong>Etihad<\/strong>, <strong>Qatar Airways<\/strong>, and <strong>Air India<\/strong>, to extend flight cancellations to <strong>Riyadh<\/strong> and other Saudi hubs through at least <strong>October 20<\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Merck KGaA (MKGAY) to acquire Silence Therapeutics (SLN) for $20.00 per ADS in an all-cash deal valued at [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[23287,31,33,130,376,665,5027,5227,16986,23286],"class_list":["post-73238","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-sln","tag-intc","tag-msft","tag-swks","tag-jnj","tag-clf","tag-semiconductors","tag-healthcare","tag-macro","tag-mkgay"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/73238","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=73238"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/73238\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=73238"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=73238"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=73238"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}